Evolus (EOLS) Operating Margin (2019 - 2026)
Evolus (EOLS) reported Operating Margin of 9.36% for Q1 2026, up 1278.0% on a YoY basis from 0.68% in Q1 2025, and down 300.36% quarter-over-quarter from 4.67% in Q4 2025.
Evolus (EOLS) Operating Margin (2019 - 2026) Analysis & Trends
Evolus has reported Operating Margin for 8 years, with the latest figure at 9.36% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin rose 1278.0% year-over-year to 9.36%; the trailing twelve-month figure through Mar 2026 stood at 8.06% (up 670.0% YoY), and the FY2025 full-year result was 10.99%, up 193.0% from the prior year.
- Operating Margin for Q1 2026 stood at 9.36%, down from 4.67% in the prior quarter.
- The five-year high for Operating Margin was 4.67% in Q4 2025, with the low at 57.44% in Q2 2022.
- Historically, Operating Margin has averaged 23.16% across 5 years, with a median of 22.14% in 2025.
- The largest YoY upside for Operating Margin was 2765 bps in 2022 against a maximum downside of 11113 bps in 2022.
- Evolus' Operating Margin stood at 24.37% in 2022, then surged by 42 bps to 14.16% in 2023, then jumped by 79 bps to 2.93% in 2024, then jumped by 259 bps to 4.67% in 2025, then sank by 300 bps to 9.36% in 2026.
- The last three Operating Margin figures came in at 9.36% (Q1 2026), 4.67% (Q4 2025), and 16.67% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -122.23% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 21.55% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -12.88% |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | -9.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.36% |
| Dec 31, 2025 | 4.67% |
| Sep 30, 2025 | -16.67% |
| Jun 30, 2025 | -14.71% |
| Mar 31, 2025 | -22.14% |
| Dec 31, 2024 | -2.93% |
| Sep 30, 2024 | -25.33% |
| Jun 30, 2024 | -11.51% |
| Mar 31, 2024 | -15.04% |
| Dec 31, 2023 | -14.16% |
| Sep 30, 2023 | -26.87% |
| Jun 30, 2023 | -30.64% |
| Mar 31, 2023 | -28.86% |
| Dec 31, 2022 | -24.37% |
| Sep 30, 2022 | -52.80% |
| Jun 30, 2022 | -57.44% |
| Mar 31, 2022 | -45.56% |
| Dec 31, 2021 | -52.02% |
| Sep 30, 2021 | -71.63% |
| Jun 30, 2021 | -58.60% |